Current Research Studies
Cancer - AALL1521: Phase 2 Study of Ruxolitinib with Chemotherapy in Children with Acute Lymphoblastic Leukemia
What is the goal of this study?
Researchers want to study the combination of ruxolitinib with chemotherapy in the treatement of B-cell acute lymphoblastic leukemia.
Who can join the study?
This study may be a good fit for children and young adults who:
- Are between 1 and 21 years old, and
- have been newly diagnosed with High-Risk, PH-like B-Accute Lymphoblastic Leukemia.
What will happen if my child takes part in this study?
You can read more about this study at clinicaltrials.gov.
Who can I contact for more information?
For more information, call 206-987-2106 or send us an email.